Literature DB >> 15313036

Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memory.

Christian Hölscher1, Susanne Schmid, Peter K D Pilz, Gilles Sansig, Herman van der Putten, Claudia F Plappert.   

Abstract

Metabotropic glutamate receptors (mGluRs), and in particular the mGluR group III receptors (subtypes 4, 6, 7, 8) are known to play a role in synaptic plasticity and learning. Here, we report the effect of mGluR7 gene ablation in different learning paradigms. In the acoustic startle response (ASR), no differences were seen between knockout (KO) mice and wildtype (WT) littermates in parameters including prepulse inhibition and habituation. In an open field test, no differences were seen between genotypes in motor activity, exploratory behaviour, and fearful behaviour. In a T-maze reinforced alternation working memory (WM) task, again no difference was seen between groups. However, when increasing the demands on working-memory in a 4-arm and 8-arm maze task, KO mice committed more WM errors than WT littermates thereby uncovering a highly significant difference between the two groups that persisted every day for the whole 9 days of the experiment. In a 4-arm maze with 2 arms baited, KO and wildtype mice committed the same number of LTM errors, whereas KOs committed more WM errors. Altogether, these findings suggest that a lack of mGluR7 mainly impairs short-term working but not long-term memory performance while having no effect on sensorimotor processing, non-associative learning, motor activity and spatial orientation. The effects on WM are task-dependent and become apparent in more complex but not simple learning tasks. We discuss how mGluR7 could influence WM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313036     DOI: 10.1016/j.bbr.2004.03.015

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  30 in total

1.  Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7.

Authors:  Zhenglin Gu; Wenhua Liu; Jing Wei; Zhen Yan
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

Review 2.  Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback.

Authors:  Lisa M Giocomo; Michael E Hasselmo
Journal:  Mol Neurobiol       Date:  2007-07-20       Impact factor: 5.590

3.  Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus.

Authors:  Rebecca Klar; Adam G Walker; Dipanwita Ghose; Brad A Grueter; Darren W Engers; Corey R Hopkins; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

4.  Maternal immune activation impairs cognitive flexibility and alters transcription in frontal cortex.

Authors:  Dionisio A Amodeo; Chi-Yu Lai; Omron Hassan; Eran A Mukamel; M Margarita Behrens; Susan B Powell
Journal:  Neurobiol Dis       Date:  2019-02-02       Impact factor: 5.996

Review 5.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

6.  Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound.

Authors:  Carson W Reed; Jacob J Kalbfleisch; Madison J Wong; Jordan P Washecheck; Ashton Hunter; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

7.  mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome.

Authors:  Rocco G Gogliotti; Rebecca K Senter; Nicole M Fisher; Jeffrey Adams; Rocio Zamorano; Adam G Walker; Anna L Blobaum; Darren W Engers; Corey R Hopkins; J Scott Daniels; Carrie K Jones; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn; Colleen M Niswender
Journal:  Sci Transl Med       Date:  2017-08-16       Impact factor: 17.956

8.  VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides.

Authors:  Carson W Reed; Kevin M McGowan; Paul K Spearing; Branden J Stansley; Hanna F Roenfanz; Darren W Engers; Alice L Rodriguez; Eileen M Engelberg; Vincent B Luscombe; Matthew T Loch; Daniel H Remke; Jerri M Rook; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2017-11-08       Impact factor: 4.345

9.  Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.

Authors:  Dana Marafi; Tadahiro Mitani; Sedat Isikay; Jozef Hertecant; Mohammed Almannai; Kandamurugu Manickam; Rami Abou Jamra; Ayman W El-Hattab; Jaishen Rajah; Jawid M Fatih; Haowei Du; Ender Karaca; Yavuz Bayram; Jaya Punetha; Jill A Rosenfeld; Shalini N Jhangiani; Eric Boerwinkle; Zeynep C Akdemir; Serkan Erdin; Jill V Hunter; Richard A Gibbs; Davut Pehlivan; Jennifer E Posey; James R Lupski
Journal:  Ann Clin Transl Neurol       Date:  2020-04-14       Impact factor: 4.511

Review 10.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.